These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 23299550

  • 1. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9.
    Jiang M, Huang O, Zhang X, Xie Z, Shen A, Liu H, Geng M, Shen K.
    Molecules; 2013 Jan 08; 18(1):701-20. PubMed ID: 23299550
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH.
    PLoS One; 2015 Jan 08; 10(7):e0132285. PubMed ID: 26158266
    [Abstract] [Full Text] [Related]

  • 3. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM, Sorokin DV, Tatarskiy VV, Prokhorov NS, Semina SE, Berstein LM, Krasil'nikov MA.
    IUBMB Life; 2016 Apr 08; 68(4):281-92. PubMed ID: 26892736
    [Abstract] [Full Text] [Related]

  • 4. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
    Wu C, Luo J.
    Med Sci Monit; 2016 Oct 21; 22():3860-3867. PubMed ID: 27765938
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells.
    Leung E, Kim JE, Rewcastle GW, Finlay GJ, Baguley BC.
    Cancer Biol Ther; 2011 Jun 01; 11(11):938-46. PubMed ID: 21464613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cells.
    Huang O, Xie Z, Zhang W, Lou Y, Mao Y, Liu H, Jiang M, Shen K.
    Oncol Rep; 2014 Aug 01; 32(2):627-34. PubMed ID: 24919713
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells.
    Biswas S, Mahapatra E, Ghosh A, Das S, Roy M, Mukherjee S.
    Asian Pac J Cancer Prev; 2021 Mar 01; 22(3):957-970. PubMed ID: 33773562
    [Abstract] [Full Text] [Related]

  • 16. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
    Bava SV, Sreekanth CN, Thulasidasan AK, Anto NP, Cheriyan VT, Puliyappadamba VT, Menon SG, Ravichandran SD, Anto RJ.
    Int J Biochem Cell Biol; 2011 Mar 01; 43(3):331-41. PubMed ID: 20883815
    [Abstract] [Full Text] [Related]

  • 17. Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.
    Zhang X, Mu X, Huang O, Xie Z, Jiang M, Geng M, Shen K.
    PLoS One; 2013 Mar 01; 8(8):e72053. PubMed ID: 23991038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.